Stock·NASDAQ·Technology
Pagaya Technologies Ltd. (PGY)
- Market cap
- $1.44B
- P/E
- 13.78
- Dividend yield
- 0.00%
- Street target
- $27.00median of 11 analysts
- 52-week range
- $10.40 $31.06
The short version
Where PGY stands today, in four lines, and what CleaRank Financial AI makes of it.
PGY at a glance
Pagaya Technologies Ltd. (PGY): Buy, 66/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($16.71 and $20.09).
- Earnings PGY beat estimates in 5 of its last 7 quarters, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $23.7M and bought $501K over the last 18 months.
- Valuation P/E of 13.8 against 35.1 for the Technology sector: a discount to peers (-61%).
Figures as of October 17, 2026.
CleaRank Financial AI
PGY earns a Buy rating from CleaRank, with a model score of 66/100.
The analysts' outlook is the biggest contributor, with 11 of 11 analysts rating the stock a buy and a median target 56.7% above the price. Momentum weighs on the score most, as the MACD line is negative. The trend is mixed, with the price 14.24% below its 50-day average of $20.09 but 3.10% above its 200-day average of $16.71. Across the past year, the stock dropped 37.80%.
Only on CleaRank
Figures we compute ourselves from PGY's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
2/4Price above its 50-day average ›
The price of $17.23 is 14.2% below the 50-day simple moving average of $20.09.Price above its 200-day average ›
The price is 3.1% above the 200-day simple moving average of $16.71.50-day average above the 200-day ›
The 50-day average ($20.09) is 20.2% above the 200-day average ($16.71), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 33% of its 52-week range, between $10.40 and $31.06.
PGY share price
Pick a period: each tab shows how far PGY has moved over it, to the last close.
Today's trading
Where PGY sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/4P/E below the sector median ›
The trailing P/E of 13.78 is 60.7% below the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 1.07 is 85.9% below the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $122.5M on revenue of $1.4B, a net margin of 8.8%.Beat estimates in most recent reports ›
PGY beat the EPS estimate in 5 of its last 7 reports.
Key statistics
The headline figures for PGY.
As of October 17, 2026, PGY trades at $17.23, with a market value of $1.44B and a P/E ratio of 13.78.
What the numbers say
CleaRank Financial AI's reading of PGY's valuation, growth and risks.
On earnings, Pagaya Technologies Ltd. (PGY) is valued at 13.78 times, against a median of 35.1 for Technology: a discount to peers, with the P/E 60.7% below that median. PGY trades at 1.07 times its sales, 85.9% below the sector median of 7.6. The company has a market capitalisation of $1.4B and trailing earnings of $1.30 a share.
With revenue growth of 18.60%, PGY is 5.6 percentage points slower than the sector median of 24.2%. Profitability shows a net margin of 9.12% and an operating margin of 27.34%, with a return on equity of 19.46%, above the sector median of 13.4%. The balance sheet rounds out the picture, with debt-to-equity of 1.34.
In its latest quarterly report, on July 30, 2026, PGY reported EPS of $1.07. That result beat the analysts' figure by 48.61%. The market agreed: the stock rose 9.24% the following session.
Across its recent record, PGY has beaten estimates in 5 of the last 7 reports. Still, the share price fell in the first session after 2 of those 5 beats.
Daily swings are the main risk to plan for. On an average session, PGY moves 3.81%. The stock is 44.53% under its 52-week high of $31.06. Over the last 18 months, insiders sold $23.7M of stock and bought $501K. Insider sales are often planned ahead or made to cover taxes on vesting shares, so they carry less weight than open-market purchases.
PGY against the Technology sector
How PGY compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: PGY trades at a notable discount to sector peers (-61%), which may indicate undervaluation or specific company headwinds.
Return vs XLK: Since May 6, 2025, PGY has gained 50.0% against a gain of 71.7% for XLK.
Performance against XLK
PGY and the Technology sector fund over the same days.
Revenue and earnings
How much PGY sells, and how much of it becomes profit.
Revenue growth: Revenue grew 25.6% in FY2025 to $1.3B, from $1.0B a year earlier.
Profit margin: The net margin was 5.7% in FY2025, up from -44.4% the year before.
Profitable: PGY earned $71.4M in FY2025.
Earnings reality check
Did PGY beat what analysts expected, and how did the stock react?
Earnings record: PGY beat the analyst estimate in 5 of the last 7 quarters.
Market reaction: The stock fell in the first session after 2 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 30, 2026after close | $0.72 | $1.07 | +48.61% | +9.24% | +21.43% |
| May 7, 2026after close | $0.56 | $0.73 | +30.36% | -2.00% | -12.26% |
| Feb 9, 2026after close | $0.77 | $0.80 | +3.90% | -3.59% | -13.32% |
| Nov 10, 2025after close | $0.66 | $1.02 | +54.55% | +0.69% | -19.14% |
| Aug 7, 2025after close | $0.67 | $0.64 | -4.48% | -6.37% | +9.47% |
| May 7, 2025after close | $0.46 | $0.69 | +50.00% | +23.29% | +33.87% |
| Feb 13, 2025after close | $0.32 | $0.17 | -46.88% | +4.99% | -0.96% |
As of October 17, 2026, PGY has beaten the analyst EPS estimate in 5 of its last 7 reported quarters and fell in the first trading session after 2 of those beats; its latest report, on July 30, 2026, came in 48.61% above the estimate and the stock moved +9.24% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 40.8, in neutral territory.RSI above 50 ›
An RSI of 40.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of PGY
The score, the reasoning behind it, and what could move the price next.
PGY shows a mixed trend. At $17.23, the stock is 14.24% below its 50-day average of $20.09, yet 3.10% above its 200-day average of $16.71. Its 52-week range runs from $10.40 to $31.06, and the price sits at 33% of that span, 44.53% below the high.
Short-term and long-term signals disagree. Over the past month the price dropped 20.38%, yet over the past three months it climbed 0.47%, and over the past year it slid 37.80%. Momentum is quiet for now: the 14-day RSI sits at 40.8, in the neutral zone, and the MACD line is negative.
Earnings beat ›
The July 30, 2026 report beat the EPS estimate by 48.61%, and the share price rose 9.24% in the first session after it.
Source: Earnings report, July 30, 2026
Rating reaffirmed ›
TD Cowen kept its Buy rating on October 6, 2026.
Source: Analyst action, TD Cowen, October 6, 2026
- The two nearest levels matter most: the 20-day EMA at $18.28 above the price and the 200-day SMA at $16.71 below it.
- The 14-day RSI reads 40.8, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price climbed 9.24% in the first session after the July 30, 2026 report. Over the past 7 reports, PGY has beaten estimates in 5 of them.
PGY's trend is mixed. The price sits above its 200-day average of $16.71 but under its 50-day average of $20.09. Closing above the 50-day would flip both signals to up, while closing below the 200-day would flip both to down. On the way up, the first hurdle is the 20-day EMA at $18.28; on the way down, the first support is the 200-day SMA at $16.71.
Technical indicators
Momentum and trend for PGY, from its daily closes.
As of October 17, 2026, with PGY at $17.23, its 14-day RSI is 40.8 (neutral territory), its 50-day simple moving average is $20.09 and its 200-day is $16.71.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What PGY moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, PGY's 1-year correlation of daily returns is +0.46 with S&P 500 (SPY), +0.44 with Nasdaq 100 (QQQ), +0.40 with Bitcoin (BTC) and +0.03 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
11 of 11 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $27.00 is 56.7% above the price.More buy ratings than three months ago ›
11 of 11 rate it a buy now, against 10 of 10 three months ago.
PGY Wall Street View
12-month price targets
The price, $17.23, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 6, 2026 | TD Cowen | Maintains | Buy |
| Sep 29, 2026 | StoneX | Reiterates | Buy |
| Aug 18, 2026 | Jefferies | Maintains | Buy |
| Jul 31, 2026 | B. Riley Securities | Maintains | Buy |
| Jul 31, 2026 | Citizens | Maintains | Market Outperform |
| Jul 31, 2026 | Canaccord Genuity | Maintains | Buy |
As of October 17, 2026, 11 Wall Street analysts cover PGY: 11 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $23.00 to $36.00, with a median of $27.00, 56.7% above the price of $17.23.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
PGY trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
PGY moves about 3.8% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much PGY tends to move, against the market and on its own.
The long record
PGY's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 3.81% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 97.2%, from August 2022 to December 2022; the price is still 92.9% below that peak.Most 1-year holds ended higher ›
37% of 1-year holding periods in the last 5 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in April 2021 is now worth $1,435.83, against $19,736 in the S&P 500 (SPY).
PGY Drawdowns & Recovery
As of October 17, 2026, PGY's worst peak-to-trough fall over the last 5 years with dividends reinvested was -97.2% (August 2022 to December 2022); it is still 92.9% below that peak, and 37% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into PGY in April 2021 is worth now, against the same amount in the S&P 500.
Against the market: PGY trailed the S&P 500 over this period: $1,435.83 against $19,736.
A $10,000 investment in PGY in April 2021 would be worth about $1,436 today with dividends reinvested, compared with about $19,736 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to PGY, and which have not.
Strongest month, July: an average of +80.73%, up in 5 of 6 years.
Weakest month, September: an average of -30.56%, up in 1 of 6 years.
This month, October: has averaged -8.73%, up in 2 of 5 years. Past seasonality does not repeat on schedule.
Over the last 6 years, PGY's strongest calendar month has been July (average +80.73%, up in 5 of 6 years) and its weakest September (average -30.56%, up in 1 of 6 years).
Average return for each calendar month over the last 6 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in PGY, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in PGY today could grow to about $3,450 by 2036 in the base case, with a 90th-percentile outcome near $26,175 and a 10th-percentile outcome around $455. Projections are statistical simulations, not guarantees.
PGY Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $11.26 for PGY by 2030 in the base case, from $17.23 today (0.7x over 4 years). The 10th-percentile path ends near $3.12. These are outcomes of a Monte Carlo simulation run on PGY's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $8.16 | $15.49 | $29.40 | |
| 2028 | $5.63 | $13.93 | $34.47 | |
| 2029 | $4.13 | $12.52 | $37.99 | |
| 2030 | $3.12 | $11.26 | $40.55 | |
| 2031 | $2.42 | $10.12 | $42.41 |
Method: a lognormal simulation of PGY's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
PGY insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $501K on the open market and sold $23.7M.
As of October 17, 2026, PGY insiders reported 60 open-market sales worth $23.7M and 2 open-market purchases worth $501K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Tami Rosen
Director
|
Sell | 2.0K | $35.4K |
| Sep 28, 2026 | Sanjiv Das
President
|
Sell | 14.3K | $243.7K |
| Sep 28, 2026 | Cory Vieira
Officer
|
Sell | 2.2K | $37.0K |
| Sep 28, 2026 | Jonathan Dobres
Chief Financial Officer
|
Sell | 590 | $10.1K |
| Sep 25, 2026 | Sanjiv Das
President
|
Grant | 25.0K | - |
| Sep 25, 2026 | Jonathan Dobres
Chief Financial Officer
|
Grant | 1.1K | - |
| Sep 25, 2026 | Cory Vieira
Officer
|
Grant | 3.6K | - |
| Sep 17, 2026 | Jonathan Dobres
Chief Financial Officer
|
Sell | 2.2K | $45.9K |
| Sep 15, 2026 | Jonathan Dobres
Chief Financial Officer
|
Grant | 4.4K | - |
| Sep 11, 2026 | Sanjiv Das
President
|
Sell | 13.3K | $268.8K |
| Sep 11, 2026 | Tami Rosen
Director
|
Sell | 7.1K | $143.9K |
| Sep 11, 2026 | Jonathan Dobres
Chief Financial Officer
|
Sell | 985 | $18.0K |
| Sep 11, 2026 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Sep 11, 2026 | Jonathan Dobres
Chief Financial Officer
|
Grant | 2.2K | - |
| Sep 11, 2026 | Tami Rosen
Director
|
Grant | 15.6K | - |
| Sep 3, 2026 | Tami Rosen
Director
|
Sell | 1.3K | $29.2K |
| Sep 2, 2026 | Cory Vieira
Officer
|
Sell | 3.1K | $69.8K |
| Sep 2, 2026 | Cory Vieira
Officer
|
Grant | 5.2K | - |
| Sep 1, 2026 | Jason M Ph.d. Gardner
Director
|
Grant | 5.9K | - |
| Aug 3, 2026 | Tami Rosen
Director
|
Sell | 28.2K | $619.4K |
| Aug 3, 2026 | Sanjiv Das
President
|
Sell | 21.3K | $468.4K |
| Aug 3, 2026 | Tami Rosen
Director
|
Grant | 7.3K | - |
| Jun 25, 2026 | Sanjiv Das
President
|
Sell | 14.0K | $221.6K |
| Jun 25, 2026 | Cory Vieira
Officer
|
Sell | 1.5K | $23.1K |
| Jun 25, 2026 | Sanjiv Das
President
|
Grant | 25.0K | - |
| Jun 25, 2026 | Cory Vieira
Officer
|
Grant | 3.6K | - |
| Jun 24, 2026 | Gal Krubiner
Chief Executive Officer
|
Buy | 16.2K | $250.5K |
| Jun 22, 2026 | Tami Rosen
Director
|
Sell | 9.9K | $151.1K |
| Jun 12, 2026 | Sanjiv Das
President
|
Sell | 13.3K | $216.0K |
| Jun 12, 2026 | Evangelos Perros
Former
|
Sell | 11.6K | $187.6K |
| Jun 12, 2026 | Tami Rosen
Director
|
Sell | 5.7K | $92.2K |
| Jun 12, 2026 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Jun 12, 2026 | Evangelos Perros
Former
|
Grant | 20.6K | - |
| Jun 12, 2026 | Tami Rosen
Director
|
Grant | 15.6K | - |
| Jun 2, 2026 | Cory Vieira
Officer
|
Sell | 2.1K | $32.1K |
| Jun 2, 2026 | Gal Krubiner
Chief Executive Officer
|
Buy | 16.6K | $250.6K |
| Jun 2, 2026 | Cory Vieira
Officer
|
Grant | 5.2K | - |
| Apr 17, 2026 | Tami Rosen
Director
|
Sell | 9.7K | $147.2K |
| Apr 1, 2026 | Evangelos Perros
Chief Financial Officer
|
Sell | 13.0K | $147.5K |
| Apr 1, 2026 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Mar 12, 2026 | Sanjiv Das
President
|
Sell | 9.7K | $106.6K |
| Mar 12, 2026 | Evangelos Perros
Chief Financial Officer
|
Sell | 8.4K | $92.6K |
| Mar 12, 2026 | Tami Rosen
Officer and Director
|
Sell | 5.9K | $64.9K |
| Mar 12, 2026 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Mar 12, 2026 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Mar 12, 2026 | Tami Rosen
Officer and Director
|
Grant | 15.6K | - |
| Mar 2, 2026 | Cory Vieira
Officer
|
Sell | 2.5K | $27.2K |
| Mar 2, 2026 | Cory Vieira
Officer
|
Grant | 5.2K | - |
| Jan 5, 2026 | Evangelos Perros
Chief Financial Officer
|
Sell | 9.8K | $224.2K |
| Jan 5, 2026 | Sanjiv Das
President
|
Sell | 3.9K | $90.7K |
| Dec 31, 2025 | Sanjiv Das
President
|
Grant | 8 | - |
| Dec 31, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Dec 19, 2025 | Tami Rosen
Officer and Director
|
Sell | 7.6K | $172.8K |
| Dec 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 11.6K | $259.1K |
| Dec 12, 2025 | Tami Rosen
Officer and Director
|
Sell | 8.1K | $180.2K |
| Dec 12, 2025 | Sanjiv Das
President
|
Sell | 568 | $12.7K |
| Dec 12, 2025 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Dec 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Dec 12, 2025 | Tami Rosen
Officer and Director
|
Grant | 15.6K | - |
| Dec 10, 2025 | Alison Davis
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Harvey Golub
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Asheet Mehta
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Dan Petrozzo
Director
|
Grant | 11.4K | - |
| Dec 10, 2025 | Avi Zeevi
Director
|
Grant | 11.4K | - |
| Dec 2, 2025 | Cory Vieira
Officer
|
Sell | 8.4K | $195.4K |
| Dec 2, 2025 | Cory Vieira
Officer
|
Grant | 20.8K | - |
| Oct 16, 2025 | Sanjiv Das
President
|
Sell | 12.8K | $351.2K |
| Oct 16, 2025 | Sanjiv Das
President
|
Grant | 22.9K | - |
| Oct 13, 2025 | Tami Rosen
Officer and Director
|
Option | 9.4K | $100.0K |
| Oct 1, 2025 | Tami Rosen
Officer and Director
|
Sell | 15.0K | $461.8K |
| Oct 1, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 12.8K | $385.2K |
| Oct 1, 2025 | Sanjiv Das
President
|
Sell | 4.8K | $144.4K |
| Oct 1, 2025 | Sanjiv Das
President
|
Grant | 8.5K | - |
| Oct 1, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Sep 15, 2025 | Tami Rosen
Officer and Director
|
Sell | 13.9K | $571.4K |
| Sep 15, 2025 | Sanjiv Das
President
|
Sell | 13.3K | $540.4K |
| Sep 15, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 11.6K | $469.3K |
| Sep 15, 2025 | Dan Petrozzo
Director
|
Sell | 2.8K | $117.2K |
| Sep 15, 2025 | Tami Rosen
Officer and Director
|
Option | 21.5K | $62.3K |
| Sep 12, 2025 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Sep 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Sep 9, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 23.8K | $902.4K |
| Aug 28, 2025 | Sanjiv Das
President
|
Sell | 12.1K | $448.6K |
| Jul 18, 2025 | Dan Petrozzo
Director
|
Sell | 8.5K | $255.8K |
| Jul 17, 2025 | Sanjiv Das
President
|
Sell | 12.7K | $330.7K |
| Jul 16, 2025 | Sanjiv Das
President
|
Grant | 22.9K | - |
| Jul 3, 2025 | Tami Rosen
Officer and Director
|
Sell | 28.5K | $632.6K |
| Jul 2, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 12.8K | $287.9K |
| Jul 2, 2025 | Sanjiv Das
President
|
Sell | 4.8K | $108.0K |
| Jul 1, 2025 | Sanjiv Das
President
|
Grant | 8.5K | - |
| Jul 1, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 22.8K | - |
| Jul 1, 2025 | Tami Rosen
Officer and Director
|
Grant | 28.5K | - |
| Jun 25, 2025 | Tami Rosen
Officer and Director
|
Sell | 10.0K | $202.4K |
| Jun 12, 2025 | Sanjiv Das
President
|
Sell | 13.6K | $242.6K |
| Jun 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Sell | 11.8K | $210.6K |
| Jun 12, 2025 | Tami Rosen
Officer and Director
|
Sell | 8.2K | $146.5K |
| Jun 12, 2025 | Sanjiv Das
President
|
Grant | 23.8K | - |
| Jun 12, 2025 | Evangelos Perros
Chief Financial Officer
|
Grant | 20.6K | - |
| Jun 12, 2025 | Tami Rosen
Officer and Director
|
Grant | 15.6K | - |
| Jun 10, 2025 | Tami Rosen
Officer and Director
|
Sell | 13.8K | $244.2K |
| Jun 3, 2025 | Sanjiv Das
President
|
Sell | 31.4K | $538.2K |
| May 14, 2025 | Yahav Haim Yulzari
Officer and Director
|
Sell | 20.8K | $314.1K |
| May 13, 2025 | Yahav Haim Yulzari
Officer and Director
|
Sell | 355.7K | $5.4M |
| May 12, 2025 | Avital Pardo
Chief Technology Officer
|
Sell | 116.5K | $1.8M |
| May 8, 2025 | Avital Pardo
Chief Technology Officer
|
Sell | 165.5K | $2.0M |
| May 8, 2025 | Yahav Haim Yulzari
Officer and Director
|
Sell | 160.7K | $2.0M |
| May 2, 2025 | Avital Pardo
Chief Technology Officer
|
Sell | 1.2K | $14.4K |
| May 2, 2025 | Yahav Haim Yulzari
Officer and Director
|
Sell | 925 | $11.1K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.